Global Rare Biomarkers Specimen Collection And Stabilization Market 2024 - By Size, Share, Price, Growth, Analysis, Outlook And Forecast Report 2033
Rare biomarkers specimen
collection and stabilization refers to the process of collecting and preserving
biological samples containing rare or low-abundance molecules that serve as
indications of specific biological processes, diseases, or situations. These
biomarkers could be specific proteins, nucleic acids, metabolites, or other
substances. The aim of collecting and preserving rare biomarkers is to enable
accurate and reliable measurement and analysis of these molecule for
diagnostic, prognostic, and therapeutic applications.
Sizing and Forecast
The rare biomarkers specimen
collection and stabilization market size has grown rapidly in recent years. It
will grow from $29.02 billion in 2023 to $32.01 billion in 2024 at a compound
annual growth rate (CAGR) of 10.3%. The growth in the historic period can be
attributed to the human genome project, increase in cancer research,
pharmaceutical R&D investment, growth of genomics and proteomics, and
improved data management and bioinformatics.
The rare biomarkers specimen
collection and stabilization market size is expected to see rapid growth in the
next few years. It will grow to $47.59 billion in 2028 at a compound annual
growth rate (CAGR) of 10.4%. The growth in the forecast period can be
attributed to the expansion of liquid biopsy applications, consumer awareness
and demand, increasing adoption of non-invasive techniques, and biomarker
discovery in rare diseases. Major trends in the forecast period include
advancements in preservation technology, growth in genomic and proteomic
research, the emergence of point-of-care testing, and regulatory advancements
and standardization, enhanced data analytics, and AI integration.
Order your report now for swift
delivery, visit the link:
Segmentation & Regional
Insights
The rare biomarkers specimen
collection and stabilization market covered in this report is segmented –
1) By Type: Circulating
Cell Free Deoxyribonucleic Acid (CCFDNA), Circulating Tumor Cells (CTCs),
Exosomes or Extracellular Vesicles
2) By Specimen: Serum Or
Plasma, Other Specimens
3) By Application:
Non-Invasive Prenatal Testing (NIPT), Oncology, Transcriptomics,
Pharmacogenomics, Transplant Rejection, Population Screening, Cardiovascular
Diseases, Other Applications
4) By End-User: Hospitals,
Perinatal Clinics, Public Health Labs, Private Or Commercial Labs, Physician
Labs, Research Institutes, Other End-Users
North America was the largest
region in the rare biomarkers specimen collection and stabilization market in
2023. Asia-Pacific is expected to be the fastest-growing region in the forecast
period. The regions covered in the rare biomarkers specimen collection and
stabilization market report are Asia-Pacific, Western Europe, Eastern Europe,
North America, South America, Middle East and Africa.
Intrigued to explore the
contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15913&type=smp
Major Driver Impacting Market
Growth
The increasing prevalence of
cancer is expected to propel the growth of the rare biomarker specimen
collection and stabilization market going forward. Cancer is a group of
diseases defined by the uncontrolled proliferation and spread of abnormal
cells. The prevalence of cancer is rising owing to environmental pollutants and
lifestyle factors, such as smoking and poor diet choices, exacerbating genetic
predispositions. The utilization of rare biomarker specimen collection and
stabilization methods in cancer prevalence studies facilitates more accurate
detection and monitoring of specific cancer types, enhancing diagnostic and
therapeutic approaches. For instance, in October 2023, according to a report by
the European Commission, a Europe-based governing body, new cancer cases rose
to 2.74 million in 2022, indicating a 2.3% increase from 2020. Therefore, the
increasing prevalence of cancer is driving the growth of the rare biomarker
specimen collection and stabilization market.
Key Industry Players
Major companies operating in the
rare biomarkers specimen collection and stabilization market are F. Hoffmann-La
Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA,
Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies
Inc., PerkinElmer Inc., Illumina Inc., Charles River Laboratories International
Inc., Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Miltenyi
Biotec GmbH, Natera Inc., Promega Corporation, Myriad Genetics, Hamilton
Company, OraSure Technologies Inc., Fluidigm Corporation, Streck Inc.,
SeraCare, Enzo Biochem Inc., Epigenomics AG, Veridex LLC
The rare biomarkers specimen
collection and stabilization market report table of contents includes:
1. Executive Summary
2. Rare Biomarkers Specimen
Collection And Stabilization Market Characteristics
3. Rare Biomarkers Specimen
Collection And Stabilization Market Trends And Strategies
4. Rare Biomarkers Specimen
Collection And Stabilization Market - Macro Economic Scenario
5. Global Rare Biomarkers Specimen
Collection And Stabilization Market Size and Growth
.............................
32. Global Rare Biomarkers
Specimen Collection And Stabilization Market Competitive Benchmarking
33. Global Rare Biomarkers
Specimen Collection And Stabilization Market Competitive Dashboard
34. Key Mergers And Acquisitions
In The Rare Biomarkers Specimen Collection And Stabilization Market
35. Rare Biomarkers Specimen
Collection And Stabilization Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Comments
Post a Comment